medical
device
news
Vektor Medical, Inc. has gained U.S. FDA 510(k) clearance for its novel computational ECG mapping system, vMap™. The non-invasive technology … continue reading “vMAP™ Arrhythmia Hot Spot Detection System FDA Cleared”
According to a well-known Berlin cardiologist, monitoring devices enable physicians to treat patients more effectively. The BioMonitor from BIOTRONIK is now approved for full-body MR scans.
Results from the St Jude sponsored ASSERT study has found that pacemaker patients who have no history of atrial tachycardia (AT) or AF, but do have device-detected arrhythmias, are approximately 2.5 times more likely to have a stroke than patients who do not have device-detected arrhythmias.
Heart rhythm records and calls about shocks from a registry of 14,475 patients with wearable defibrillators listed from 2007 through 2009 show 91.6 percent survived one or more episodes of ventricular fibrillation or ventricular tachycardia.
Welsh technology company, Ceryx Medical has announced a first patient enrollment in the RSA-Pace multi-centre study. The study aims to evaluate the … continue reading “Temporary Pacing System: First-In-Human Study of the Ceryx Medical Cysoni™ RSA Pacemaker”
Boston Scientific says its acquisition of Cortex, Inc., will complement electrophysiology portfolio with solution to advance the treatment of complex … continue reading “Boston Scientific to Acquire Atrial Fibrillation Tech Company Cortex, Inc.”
Biosense Webster, Inc., has announced European CE mark approval of the VARIPULSE™ Platform. The approval covers the treatment of symptomatic drug refractory … continue reading “VARIPULSE™ Pulse Field Ablation (PFA) Platform Gains CE Mark”
Swiss company Argá Medtech has begun enrollment in a First-in-Human Clinical Trial of its CSE Ablation System in the treatment … continue reading “First-in-Human Trial will Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation”
Argá Medtech’s next-generation non-thermal cardiac ablation system shows promise in improving precision, speed and flexibility in treating atrial fibrillation, says … continue reading “Study Shows Promise for Next-Generation Cardiac Ablation Tech”
Imagine four-dimensional (4D) imagery of the beating heart, viewed live, in 360°. Now add real-time tissue analysis to the same … continue reading “$17m New Finance for 4D Cardiac Imaging Tech”
Johnson & Johnson Medical Devices Companies’ Biosense Webster, Inc., says the first patients have been enrolled and treated in its … continue reading “First Patients in Europe Treated with Biosense Webster VARIPULSE® AF Catheter”
Johnson & Johnson Medical Devices Companies have announced the U.S. FDA approval of Biosense Webster, Inc.’s THERMOCOOL SMARTTOUCH® SF Ablation … continue reading “FDA Approval for Biosense Webster THERMOCOOL SMARTTOUCH® SF Ablation Catheter for Persistent Atrial Fibrillation”
Multicenter study will evaluate balloon ablation catheter for safety and effectiveness in achieving pulmonary vein isolation in paroxysmal AF treatment
Persistent Paroxysmal Atrial Fibrillation in focus for heart rhythm specialist
Biosense Webster, Inc. launches U.S. study to evaluate the safety and efficacy of the WaveCrest® Left Atrial Appendage Occlusion System
Low-Cost cardiac screening advancement aims to improve early detection of heart disease
